Clinical Trial Update: Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an orally administered medication in combination with pramlintide in adults with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Orally administered investigational medication
• pramlintide (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 2 | Status: COMPLETED